GENE ONLINE|News &
Opinion
Blog

Uncategorized
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
320 World Oral Health Day – Lifting the “mask mandate”, maintaining good oral hygiene and flashing a healthy and confident smile.
2023-03-19
Illumina launches its first product enabling long- and short-read sequencing on one instrument
2023-03-14
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
2023-02-28
On Rare Disease Day 2023 RemeGen Highlights Its Social Responsibility and Rare Disease Advocacy
2023-02-27
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
2023-02-27
Illumina Reveals NovaSeq™ X Series at the Illumina Genomics Forum
2022-09-29
QOL Medical’s Sucraid Single-Use Containers Approved For Patients With Sucrase Deficiency
2022-09-07
Ginkgo Bioworks Buys Baktus’ Epidemic-Predicting Tools
2022-08-22
New Long-acting Formulation could be Key in Curing TB
2022-08-10
Novel Inhalable COVID-19 Therapeutic Targeting Viral Replication
2022-08-10
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
After Winning Approval for Its Painkiller in Thailand, Taiwan’s Lumosa Aims for Korea Nod
2022-01-02
1 2
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top